Skip to main content

You must have JavaScript enabled in order to access this part of the site. Please enable JavaScript and then reload this page in order to continue.

Reimbursement Rate Changes and Updates for PAD Oncology and Non-Oncology Procedure Codes Effective September 1, 2026

Last updated on

Effective for dates of service on or after September 1, 2026, the Texas Medicaid & Healthcare Partnership (TMHP) implemented the reimbursement rate changes and updates for the Physician-Administered Drugs (PAD) Oncology and Non-Oncology procedure codes that were presented at the public rate hearing on May 26, 2026.

Calendar Fee Review for the following drug categories was covered at the public hearing:

For more information, call the TMHP Contact Center at 800-925-9126.

Note: Texas Medicaid managed care organizations (MCOs) must provide all medically necessary, Medicaid-covered services to Medicaid members who are enrolled in their MCO. Administrative procedures, such as prior authorization, precertification, referrals, and claims and encounter data filing, may differ from traditional Medicaid (fee-for-service) and from MCO to MCO. Providers should contact the member’s specific MCO for details.